Ataxic hemiparesis: the benefit of acute multiparametric magnetic resonance imaging.
Cho
Tae-Hee
TH
Hermier
Marc
M
Derex
Laurent
L
Trouillas
Paul
P
Nighoghossian
Norbert
N
D000368:Aged; D001259:Ataxia / Q000150:complications / Q000473:pathology* / Q000503:physiopathology; D020526:Brain Stem Infarctions / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000502:physiology*; D003287:Contrast Media; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D020762:Infarction, Posterior Cerebral Artery / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology; D018810:Magnetic Resonance Angiography / Q000379:methods*; D008297:Male; D010291:Paresis / Q000150:complications / Q000473:pathology* / Q000503:physiopathology; D020769:Posterior Cerebral Artery / Q000473:pathology / Q000503:physiopathology; D013681:Tegmentum Mesencephali / Q000098:blood supply / Q000473:pathology / Q000503:physiopathology; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D016896:Treatment Outcome; D020651:Ventral Thalamic Nuclei / Q000098:blood supply / Q000473:pathology / Q000503:physiopathology
D003287:Contrast Media; D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator